Babak Arjmand

Babak Arjmand


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2008 in Neuroscience Letters
Verified
Journal Article
Closed access
HSHooshang Saberi
Hooshang Saberi
PMPouria Moshayedi
Pouria Moshayedi
HAHamidreza Aghayan
Hamidreza Aghayan
BABabak Arjmand
Babak Arjmand
SHSeyed-Kazem Hosseini
Seyed-Kazem Hosseini
MFMasoumeh Firouzi
Masoumeh Firouzi

27 January 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
BABabak Arjmand
Babak Arjmand
SHShayesteh Kokabi Hamidpour
Shayesteh Kokabi Hamidpour
ATAkram Tayanloo-Beik
Akram Tayanloo-Beik
PGParisa Goodarzi
Parisa Goodarzi
HAHamid Reza Aghayan
Hamid Reza Aghayan
BLBagher Larijani
Bagher Larijani
Cancer is defined as a large group of diseases that is associated with abnormal cell growth, uncontrollable cell division, and may tend to impinge on other tissues of the body by different mechanisms through metastasis. What makes cancer so important is that the cancer incidence rate is growing worldwide which can have major health, economic, and even social impacts on both patients and the governments. Thereby, the early cancer prognosis, diagnosis, and treatment can play a crucial role at the front line of combating cancer. The onset and progression of cancer can occur under the influence of complicated mechanisms and some alterations in the level of genome, proteome, transcriptome, metabolome etc. Consequently, the advent of omics science and its broad research branches (such as genomics, proteomics, transcriptomics, metabolomics, and so forth) as revolutionary biological approaches have opened new doors to the comprehensive perception of the cancer landscape. Due to the complexities of the formation and development of cancer, the study of mechanisms underlying cancer has gone beyond just one field of the omics arena. Therefore, making a connection between the resultant data from different branches of omics science and examining them in a multi-omics field can pave the way for facilitating the discovery of novel prognostic, diagnostic, and therapeutic approaches. As the volume and complexity of data from the omics studies in cancer are increasing dramatically, the use of leading-edge technologies such as machine learning can have a promising role in the assessments of cancer research resultant data. Machine learning is categorized as a subset of artificial intelligence which aims to data parsing, classification, and data pattern identification by applying statistical methods and algorithms. This acquired knowledge subsequently allows computers to learn and improve accurate predictions through experiences from data processing. In this context, the application of machine learning, as a novel computational technology offers new opportunities for achieving in-depth knowledge of cancer by analysis of resultant data from multi-omics studies. Therefore, it can be concluded that the use of artificial intelligence technologies such as machine learning can have revolutionary roles in the fight against cancer.

1 November 2011 in Journal of Neurosurgery: Spine
Verified
Journal Article
Closed access
HSHooshang Saberi
Hooshang Saberi
MFMasoumeh Firouzi
Masoumeh Firouzi
ZHZohreh Habibi
Zohreh Habibi
PMPouria Moshayedi
Pouria Moshayedi
HAHamidreza Aghayan
Hamidreza Aghayan
MYMir Saeed Yekaninejad
Mir Saeed Yekaninejad
Object: Many experimental studies on spinal cord injuries (SCIs) support behavioral improvement after Schwann cell treatment. This study was conducted to evaluate safety issues 2 years after intramedullary Schwann cell transplantation in 33 consecutively selected patients with SCI. Methods: Of 356 patients with SCIs who had completed at least 6 months of a conventional rehabilitation program and who were screened for the study criteria, 33 were enrolled. After giving their informed consent, they volunteered for participation. They underwent sural nerve harvesting and intramedullary injection of a processed Schwann cell solution. Outcome assessments included a general health questionnaire, neurological examination, and functional recordings in terms of American Spinal Injury Association (ASIA) and Functional Independence Measure scoring, which were documented by independent observers. There were 24 patients with thoracic and 9 with cervical injuries. Sixteen patients were categorized in ASIA Grade A, and the 17 remaining participants had ASIA Grade B. Results: There were no cases of deep infection, and the follow-up MR imaging studies obtained at 2 years did not reveal any deformity related to the procedure. There was no case of permanent neurological worsening or any infectious or viral complications. No new increment in syrinx size or abnormal tissue and/or tumor formation were observed on contrast-enhanced MR imaging studies performed 2 years after the treatment. Conclusions: Preliminary results, especially in terms of safety, seem to be promising, paving the way for future cell therapy trials.

1 June 2018
Verified
Book Chapter
Closed access
PDF file
PGParisa Goodarzi
Parisa Goodarzi
KFKhadijeh Falahzadeh
Khadijeh Falahzadeh
MNMehran Nematizadeh
Mehran Nematizadeh
PFParham Farazandeh
Parham Farazandeh
MPMoloud Payab
Moloud Payab
BABabak Arjmand
Babak Arjmand

14 May 2013 in Archives of Neuroscience
Verified
Journal Article
Open access
PDF file
JAJafar Ai
Jafar Ai
AKAnahita Kiasat-Dolatabadi
Anahita Kiasat-Dolatabadi
SESomayeh Ebrahimi-Barough
Somayeh Ebrahimi-Barough
AAArmin Ai
Armin Ai
NLNasrin Lotfibakhshaiesh
Nasrin Lotfibakhshaiesh
HAHamid Reza Aghayan
Hamid Reza Aghayan
Context: The nervous system is the most important system of the body and damaging this system could be lethal for humans. Restoring the function of a damaged nervous system has always been a challenge due to the complexity of this system and its limited ability of regeneration. Furthermore, several obstacles exist in the repair process of the nervous system. Evidence Acquisitions: In the central nervous system (CNS) limited clearance of myelin and formation of inhibitory glial scars make regeneration difficult. There is no effective clinical treatment for damages in the CNS while current treatments focus on stabilization and prevention of further damage and consequently on rehabilitation and preparation of prosthetics and mechanical aids. In peripheral nervous system (PNS) damages, the management may be a nerve autograft or allograft while shortage of donors for nerves makes the situation difficult. Size inequality between the donor nerve and the recipient, danger of neuroma formation and occurrence of infectious diseases are other problems associated with PNS, while indeed complete recovery of function is still not common. Results: Several studies have illustrated that implying tissue engineering strategies for neural repair may lead to considerable improvements in damaged nervous tissues. The development of a scaffold that is similar to the natural extracellular matrix can provide an ideal environment for three dimensional cell cultures, which is a reason for neural tissue engineering success. The need to develop biocompatible and biodegradable material that supports neural tissue growth still exists. Conclusions: This article reviews different types of polymeric materials used in neural tissue engineering and mainly focuses on their properties and their advantages and disadvantages in neural regeneration. Keywords: Polymers; Tissue Engineering; Nervous System

27 July 2018
Verified
Book Chapter
Closed access
PDF file
PGParisa Goodarzi
Parisa Goodarzi
BLBagher Larijani
Bagher Larijani
SASepideh Alavi-Moghadam
Sepideh Alavi-Moghadam
ATAkram Tayanloo-Beik
Akram Tayanloo-Beik
FMFereshteh Mohamadi-Jahani
Fereshteh Mohamadi-Jahani
BABabak Arjmand
Babak Arjmand